Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Young Pakistanis rush to purchase Russian vaccine as private sales open

Published 04/04/2021, 01:59 PM
Updated 04/04/2021, 02:31 PM
© Reuters. A resident goes through medical checkup before receiving a commercial dose of Russia's Sputnik V coronavirus disease (COVID-19) vaccine, at a private hospital in Karachi

By Syed Raza Hassan

KARACHI, Pakistan (Reuters) - Thousands of Pakistanis rushed to get inoculated in the first round of commercial sales of COVID-19 vaccines that began over the weekend, with vaccination sites in the southern city of Karachi saying on Sunday they had already sold out.

Pakistan is currently offering free vaccines to frontline healthcare workers and people over the age of 50, but the drive has thus far been slow, and last month the country allowed commercial imports by the private sector for the general public.

The first round saw the commercial sale of the two-shot Russian Sputnik V to the general public for about 12,000 Pakistani rupees ($80) for a pack of two doses.

Despite the cost, a number of centres offering the shot reported long queues, with some in Karachi waiting in line for close to three hours. Most in the queue were young Pakistanis still not eligible for government's free vaccination.

"I am very happy to get it, since now it is required for travelling," Saad Ahmed, 34, told Reuters on Sunday after he got his shot at an upscale private sector hospital in Karachi.

While the private sale of vaccines has begun, the government and importers are still locked in a pricing dispute.

Pakistan initially agreed to exempt imported vaccines from price caps, but later rescinded the exemption and said it would set maximum prices.

One pharmaceutical company, which had already imported 50,000 doses of Sputnik V, took the government to court, where it won an interim order allowing it to sell it until pricing is decided.

As soon as vaccination was opened for walk-in customers, there were long lines of people, Dr Nashwa Ahmed, who runs vaccination at Karachi's South City Hospital, told Reuters.

Pictures of queues outside the hospital late into the night were shared on social media.

The hospital procured 5,000 doses of Sputnik V and in just over two days all its stock had been administered or pre-booked, said a hospital official who asked not to be identified.

Companies, including one of Pakistan's largest banks, have also purchased large quantities to have staff inoculated, the official said.

The private sales start as the country deals with a fresh wave of COVID-19 infections and healthcare facilities are fast filling to capacity.

The number of patients now in critical care has reached 3,568, the highest since the pandemic started, a cabinet minister, Asad Umar, said on Twitter. Pakistan has thus far reported 687,908 infections and 14,778 deaths.

© Reuters. Residents sit in a waiting area after getting a commercial dose of Russia's Sputnik V coronavirus disease (COVID-19) vaccine, at a private hospital in Karachi

($1 = 152.9400 Pakistani rupees)

Latest comments

More vaccines the better
Good on them for allowing private sales. Shows how much quicker, efficiently, and fairly free markets work. There will always be charitable dollars for those who can’t afford it, which is usually also quicker and more efficient than government.
Im 100% for less tax if every single loop hole and subsidy for private business is erased
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.